WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced that a newly published clinical study demonstrates that the accuracy of the ARROW® VPS G4™ Vascular Positioning System, with placements of peripherally inserted central catheters (PICCs), can eliminate the use of confirmatory chest X-rays.
Help employers find you! Check out all the jobs and post your resume.
